HomeROVI • VIE
add
Laboratorios Farmaceuticos ROVI SA
Previous close
€86.60
Day range
€85.65 - €85.65
Year range
€38.38 - €85.65
Market cap
4.62B EUR
P/E ratio
26.75
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 151.18M | -25.02% |
Operating expense | 66.56M | 1.53% |
Net income | 14.96M | -68.48% |
Net profit margin | 9.90 | -57.94% |
Earnings per share | — | — |
EBITDA | 25.74M | -61.17% |
Effective tax rate | 21.30% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 13.08M | -90.75% |
Total assets | 778.66M | -12.03% |
Total liabilities | 254.88M | -19.44% |
Total equity | 523.78M | — |
Shares outstanding | 51.82M | — |
Price to book | 8.63 | — |
Return on assets | 6.05% | — |
Return on capital | 7.87% | — |
Cash Flow
Net change in cash
(EUR) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 14.96M | -68.48% |
Cash from operations | 15.54M | -36.58% |
Cash from investing | -9.15M | -89.45% |
Cash from financing | -18.63M | -489.65% |
Net change in cash | -12.24M | -174.09% |
Free cash flow | 3.50M | -57.98% |
About
Founded
1946
Website
Employees
1,925